Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg

4 July 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivosidenib Tablets, 250 mg. The approved ANDA is…